437 related articles for article (PubMed ID: 20200161)
1. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
Ghatak S; Hascall VC; Markwald RR; Misra S
J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
[TBL] [Abstract][Full Text] [Related]
2. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
[TBL] [Abstract][Full Text] [Related]
3. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
5. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.
Nakashiro K; Hara S; Shinohara Y; Oyasu M; Kawamata H; Shintani S; Hamakawa H; Oyasu R
Am J Pathol; 2004 Aug; 165(2):533-40. PubMed ID: 15277227
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
8. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.
Tremmel M; Matzke A; Albrecht I; Laib AM; Olaku V; Ballmer-Hofer K; Christofori G; Héroult M; Augustin HG; Ponta H; Orian-Rousseau V
Blood; 2009 Dec; 114(25):5236-44. PubMed ID: 19773544
[TBL] [Abstract][Full Text] [Related]
9. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.
Ghatak S; Bogatkevich GS; Atnelishvili I; Akter T; Feghali-Bostwick C; Hoffman S; Fresco VM; Fuchs JC; Visconti RP; Markwald RR; Padhye SB; Silver RM; Hascall VC; Misra S
J Biol Chem; 2014 Mar; 289(11):7856-72. PubMed ID: 24324260
[TBL] [Abstract][Full Text] [Related]
11. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin.
Singleton PA; Salgia R; Moreno-Vinasco L; Moitra J; Sammani S; Mirzapoiazova T; Garcia JG
J Biol Chem; 2007 Oct; 282(42):30643-57. PubMed ID: 17702746
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance.
Joosten SPJ; Spaargaren M; Clevers H; Pals ST
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188437. PubMed ID: 32976979
[TBL] [Abstract][Full Text] [Related]
13. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
14. CD44-independent activation of the Met signaling pathway by HGF and InlB.
Dortet L; Veiga E; Bonazzi M; Cossart P
Microbes Infect; 2010 Nov; 12(12-13):919-27. PubMed ID: 20670691
[TBL] [Abstract][Full Text] [Related]
15. c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.
Gordin M; Tesio M; Cohen S; Gore Y; Lantner F; Leng L; Bucala R; Shachar I
J Immunol; 2010 Aug; 185(4):2020-31. PubMed ID: 20639480
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.
Takahashi E; Nagano O; Ishimoto T; Yae T; Suzuki Y; Shinoda T; Nakamura S; Niwa S; Ikeda S; Koga H; Tanihara H; Saya H
J Biol Chem; 2010 Feb; 285(6):4060-4073. PubMed ID: 19965872
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
[TBL] [Abstract][Full Text] [Related]
18. The CD147-HYALURONAN Axis in Cancer.
Toole BP
Anat Rec (Hoboken); 2020 Jun; 303(6):1573-1583. PubMed ID: 31090215
[TBL] [Abstract][Full Text] [Related]
19. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.
Yu S; Xia S; Yang D; Wang K; Yeh S; Gao Z; Chang C
Med Oncol; 2013; 30(3):674. PubMed ID: 23925662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]